Deerfield Management’s Rubius Therapeutics RUBY Stock Holding History
Bought
Maintained
Sold
Other funds holding RUBY
AG
Deerfield Management's RUBY Position: Q2 2021 in Review
Deerfield Management sold out of Rubius Therapeutics (RUBY) in Q2 2021, closing a stake of 550,000 shares — an estimated $14.6M sold.
Deerfield Management first reported a position in RUBY in Q1 2021 and held it in 1 quarter. The position peaked at $14.6M in Q1 2021. 108 funds tracked by Wall St. Rank hold RUBY as of Q2 2021.
- Deerfield Management reported no remaining Rubius Therapeutics position as of Q2 2021 after selling out during the quarter.
- Deerfield Management sold 550,000 Rubius Therapeutics shares in Q2 2021, an estimated $14.6M.
- Deerfield Management first reported a position in Rubius Therapeutics in Q1 2021 and held it in 1 quarter.
- Deerfield Management's Rubius Therapeutics position peaked at $14.6M in Q1 2021.
- 108 funds tracked by Wall St. Rank held Rubius Therapeutics as of Q2 2021.
Based on Deerfield Management's 13F filing for Q2 2021, filed 16 Aug 2021.